At $1.15 SP, with a current cash backing of $100m against a market cap of 200m, then its time to turn on the buyback pretty soon it would seem.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025